MCID: CRN027
MIFTS: 48

Corneal Neovascularization malady

Category: Eye diseases

Aliases & Classifications for Corneal Neovascularization

About this section

Aliases & Descriptions for Corneal Neovascularization:

Name: Corneal Neovascularization 11 26 49 38 13 67

Classifications:



External Ids:

Disease Ontology11 DOID:11382
ICD1029 H16.4, H16.40
ICD9CM31 370.6, 370.60
MeSH38 D016510

Summaries for Corneal Neovascularization

About this section
Wikipedia:70 Corneal neovascularization is the excessive ingrowth of blood vessels from the limbal vascular plexus... more...

MalaCards based summary: Corneal Neovascularization is related to hypertrophy of tongue papillae and spinal cord astrocytoma, and has symptoms including vascularization of cornea An important gene associated with Corneal Neovascularization is VEGFA (Vascular Endothelial Growth Factor A), and among its related pathways are Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers and Integrins in angiogenesis. Affiliated tissues include eye, endothelial and neutrophil, and related mouse phenotypes are reproductive system and skeleton.

Related Diseases for Corneal Neovascularization

About this section

Diseases related to Corneal Neovascularization via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 71)
idRelated DiseaseScoreTop Affiliating Genes
1hypertrophy of tongue papillae10.6SERPINF1, VEGFA
2spinal cord astrocytoma10.6FLT1, VEGFA
3enamel erosion10.6FGF2, VEGFA
4spinal muscular atrophy-dandy-walker malformation-cataracts syndrome10.5FLT1, VEGFA
5silicosiderosis10.5KDR, VEGFA
6malignant gastric germ cell tumor10.5KDR, VEGFA
7intestinal benign neoplasm10.5FLT1, VEGFA
8acute lymphoblastic leukemia congenital sporadic aniridia10.5FLT1, VEGFA
9arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay10.5KDR, VEGFA
10iliac vein thrombophlebitis10.5KDR, VEGFA
11thrombophilia10.5SERPINF1, VEGFA
12postural hypotension10.5FGF2, VEGFA
13cyclothymic disorder10.5TEK, VEGFA
14ovarian fetiform teratoma10.5CXCL12, FGF2
15ocular melanoma10.4KDR, VEGFA
16striatonigral degeneration10.4FLT1, TEK
17renal artery obstruction10.4CXCL12, KDR
18speech disorder10.4FGF2, SERPINF1, VEGFA
19facial nerve disease10.4SERPINF1, VEGFA
20acute dacryocystitis10.3KDR, SERPINF1, VEGFA
21calcaneonavicular coalition10.3KDR, SERPINF1, VEGFA
22tollner horst manzke syndrome10.3FGF2, PLG, VEGFA
23gastric small cell carcinoma10.3FGF2, KDR, VEGFA
24bladder urachal carcinoma10.3FLT1, KDR, VEGFA
25lens disease10.3FLT1, KDR, VEGFA
26burns10.3
27lung carcinoma in situ10.3FGF2, KDR, VEGFA
28neuropathy, hereditary sensory, type ib10.3FGF2, KDR, VEGFA
29lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy10.3FLT1, KDR, VEGFA
30chikungunya10.3FLT1, KDR, VEGFA
31bone benign neoplasm10.3FGF2, TEK
32perivascular epithelioid cell tumor10.3KDR, VEGFA
33autoimmune polyendocrine syndrome10.3CD36, VEGFA
34endotheliitis10.3
35cystadenoma10.3FGF2, KDR, VEGFA
36epidermolysis bullosa10.3KDR, TEK, VEGFA
37vitreous abscess10.2FGF2, VEGFA
38naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis10.2FGF2, VEGFA
39intracranial hemorrhage in brain cerebrovascular malformations10.2FGF2, KDR, VEGFA
40pauciarticular onset juvenile idiopathic arthritis10.2CD36, VEGFA
41hemangioblastoma10.2FGF2, TEK
42scn8a encephalopathy10.2SERPINF1, VEGFA
43keratitis10.1
44micropapillomatosis labialis10.1THBS1, VEGFA
45osteogenesis imperfecta, type ii10.1CD36, SERPINF1
46opportunistic mycosis10.1FGF2, FLT1, KDR, VEGFA
47third cranial nerve disease10.1FLT1, KDR, SERPINF1, VEGFA
48colorectal adenoma10.0FGF2, PLG, TEK, VEGFA
49renal fibrosis10.0FGF2, KDR, TEK, VEGFA
50apocrine adenoma10.0FLT1, KDR, TEK, VEGFA

Graphical network of the top 20 diseases related to Corneal Neovascularization:



Diseases related to corneal neovascularization

Symptoms for Corneal Neovascularization

About this section

UMLS symptoms related to Corneal Neovascularization:


vascularization of cornea

Drugs & Therapeutics for Corneal Neovascularization

About this section

Drugs for Corneal Neovascularization (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 85)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
RanibizumabapprovedPhase 4, Phase 1474347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
2
Bevacizumabapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 11968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
3Antibodies, MonoclonalPhase 4, Phase 23795
4ImmunoglobulinsPhase 4, Phase 2, Phase 16045
5AntibodiesPhase 4, Phase 2, Phase 16045
6Angiogenesis InhibitorsPhase 4, Phase 2, Phase 3, Phase 14143
7Angiogenesis Modulating AgentsPhase 4, Phase 2, Phase 3, Phase 14072
8Pharmaceutical SolutionsPhase 4, Phase 3, Phase 1, Phase 27793
9AnestheticsPhase 4, Phase 29001
10
Oxytetracyclineapproved, vet_approvedPhase 2, Phase 3879-57-25280972
Synonyms:
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2E,4S,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
102287-29-6
103351-03-7
105145-10-6
106216-57-3
1405-95-4
15251-48-6
2058-46-0 (Mono-hydrochloride)
2058-46-0 (mono-hydrochloride)
21645-09-0
4-14-00-02633 (Beilstein Handbook Reference)
5-Hydroxy-Tetracycline
5-Hydroxytetracycline
52214-46-7
6153-64-6 (Di-hydrate)
6153-64-6 (di-hydrate)
6153-65-7 (Di-hydrochloride salt, di-hydrate)
6153-65-7 (di-hydrochloride salt, di-hydrate)
64038-91-1 (sulfate (2:1))
69766-62-7 (hydrochloride salt)
7179-50-2 (Calcium (1:1) salt)
7179-50-2 (calcium (1:1) salt)
79-57-2
79-57-2 (ANHYDROUS)
856305-69-6
96310-42-8
AC-12777
AC1NQXTY
AC1NQZMP
AC1NS4NE
AC1O52HP
AKOS001632631
Abbocin
Adamycin
Antibiotic TM 25
BPBio1_000302
BRN 2714587
BSPBio_000274
BSPBio_002151
Berkmycen
Biostat
Biostat PA
Biostat pa
Bisolvomycin
C06624
C22H24N2O9
CHEBI:27701
CHEMBL1517
CID5280972
CID5282186
CID5353856
CID6426716
DB00595
Dabicycline
Dalimycin
DivK1c_000225
EINECS 201-212-8
Embryostat
Fanterrin
Galsenomycin
Geomycin
Geomycin (Streptomyces vimosus)
Geotilin
HSDB 3145
Hydroxytetracycline
Hydroxytetracyclinum
IDI1_000225
Imperacin
KBio1_000225
KBio2_001535
KBio2_004103
KBio2_006671
KBio3_001651
KBioGR_000912
KBioSS_001535
LA 200
LMPK07000005
LS-93860
Lenocycline
Liquamycin
Liquamycin LA 200
 
MLS000069429
Macocyn
Medamycin
Mepatar
MolPort-002-524-946
MolPort-005-934-326
Mycoshield TMQTHC 20
NCGC00091268-04
NCGC00091268-05
NCI-C56473
NINDS_000225
NSC 9169
NSC-9169
NSC9169 (HCL)
OTC
OTC (antibiotic)
Oksisyklin
Ossitetraciclina
Ossitetraciclina [DCIT]
Oxacycline
Oxitetraciclina
Oxitetraciclina [INN-Spanish]
Oxitetracyclin
Oxitetracycline
Oxitetracyclinum
Oxy-kesso-tetra
Oxydon
Oxymycin
Oxymykoin
Oxypam
Oxysteclin
Oxyterracin
Oxyterracine
Oxyterracyne
Oxytetracid
Oxytetracyclin
Oxytetracycline (anhydrous)
Oxytetracycline (internal use)
Oxytetracycline HCl
Oxytetracycline [INN]
Oxytetracycline [inn]
Oxytetracycline amphoteric
Oxytetracycline anhydrous
Oxytetracycline calcium
Oxytetracyclinum
Oxytetracyclinum [INN-Latin]
Oxytétracycline
Pennox 200
Prestwick0_000307
Prestwick1_000307
Prestwick2_000307
Prestwick3_000307
Proteroxyna
Riomitsin
Ryomycin
S1773_Selleck
SMR000059000
SPBio_001055
SPBio_002493
STOCK1N-50853
Solkaciclina
Spectrum2_000988
Spectrum3_000536
Spectrum4_000466
Spectrum5_001148
Spectrum_001055
Stecsolin
Stevacin
TM 5
Tarocyn
Tarosin
Teravit
Terrafungine
Terramitsin
Terramycin
Terramycin Q50
Terramycin im
Terramycin, Liquamycin, Oxytetracycline
Tetran
UNII-SLF0D9077S
UNII-X20I9EN955
Unimycin
Ursocyclin
Ursocycline
Vendarcin
oxytetracycline
11
Doxycyclineapproved, investigational, vet_approvedPhase 2, Phase 3237564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
 
Doxycycline (INN)
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
12
Triamcinoloneapproved, vet_approvedPhase 2, Phase 3482124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
13
Miconazoleapproved, investigational, vet_approvedPhase 3, Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
14
Voriconazoleapproved, investigationalPhase 3127137234-62-971616
Synonyms:
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
137234-62-9
173967-54-9
AC-823
AC1L2GHR
AC1Q4O6I
AKOS005145705
C07622
C102790
CHEBI:10023
CHEMBL638
CID71616
CPD000466350
D00578
DB00582
DRG-0301
FT-0082604
HMS2051N09
LS-181799
 
MLS000759464
MLS001424082
MolPort-003-850-863
Pfizer brand of voriconazole
S1442_Selleck
SAM001246664
SMR000466350
TL8000858
UK 109,496
UK 109496
UK-109,496
UK-109496
UNII-JFU09I87TR
VCZ
VRC
Vfend
Vfend (TN)
Vfend, Voriconazole
Voriconazol
Voriconazole
Voriconazole (JAN/USAN/INN)
Voriconazole [USAN:INN:BAN]
Voriconazole in combination with MGCD290
Voriconazolum
ZINC00014864
voriconazole
15
NatamycinapprovedPhase 387681-93-85281099
Synonyms:
(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14
7681-93-8
80482_FLUKA
A 5283
AC-15226
AC1LCW93
AC1MC3GI
Antibiotic A 5283
Antibiotic A-5283
C08073
C33H47NO13
CHEMBL1200656
CID657250
CL 12,625
CL 12625
CL-12625
CPD000466358
D00884
DB00826
Delvocid
Delvolan
Delvopos
E235
EINECS 231-683-5
HMS1571M10
LS-7662
MLS000069611
MLS000759475
MolPort-003-939-127
MolPort-005-935-314
Mycophyt
Myprozine
 
NATAMYCIN
Natacyn
Natacyn (TN)
Natafucin
Natamicina
Natamicina [INN-Spanish]
Natamycin
Natamycin (USP/INN)
Natamycin [USAN:INN:BAN]
Natamycin preparation
Natamycine
Natamycine [INN-French]
Natamycinum
Natamycinum [INN-Latin]
P0440_SIGMA
P9703_SIGMA
Pimafucin
Pimafugin
Pimaracin
Pimaricin
Pimaricin (JP15)
Pimaricin preparation
Pimaricine
Pimarizin
Pimarizin [German]
Prestwick2_001104
SAM001246683
SMP1_000240
SMR000058788
SMR000466358
Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Synogil
Tennecetin
Tymasil
UNII-8O0C852CPO
pimaricin
16Anti-Bacterial AgentsPhase 2, Phase 3, Phase 110884
17AntimalarialsPhase 2, Phase 31216
18MitogensPhase 2, Phase 31526
19Endothelial Growth FactorsPhase 2, Phase 3362
20Antiparasitic AgentsPhase 2, Phase 32127
21Anti-Infective AgentsPhase 2, Phase 3, Phase 121402
22Antiprotozoal AgentsPhase 2, Phase 31986
23Hormone AntagonistsPhase 312778
24HormonesPhase 313979
25Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 312767
26triamcinolone acetonidePhase 2, Phase 3482
27Triamcinolone diacetatePhase 2, Phase 3482
28Triamcinolone hexacetonidePhase 2, Phase 3482
29Steroid Synthesis InhibitorsPhase 31718
30Cytochrome P-450 CYP3A InhibitorsPhase 31666
31Antifungal AgentsPhase 3, Phase 13615
32Anti-Infective Agents, LocalPhase 31785
33Cytochrome P-450 Enzyme InhibitorsPhase 33822
34
EphedrineapprovedPhase 1, Phase 2606299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
35
PseudoephedrineapprovedPhase 1, Phase 260690-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
36Respiratory System AgentsPhase 1, Phase 24818
37Autonomic AgentsPhase 1, Phase 29774
38Lubricant Eye DropsPhase 1, Phase 2162
39Vasoconstrictor AgentsPhase 1, Phase 22027
40Peripheral Nervous System AgentsPhase 1, Phase 222776
41Gastrointestinal AgentsPhase 1, Phase 28109
42Interleukin 1 Receptor Antagonist ProteinPhase 1, Phase 296
43Antirheumatic AgentsPhase 1, Phase 210627
44Nasal DecongestantsPhase 1, Phase 2578
45LaxativesPhase 1, Phase 2520
46Ophthalmic SolutionsPhase 1, Phase 21092
47Carboxymethylcellulose SodiumPhase 1, Phase 2172
48TetrahydrozolinePhase 1, Phase 2593
49CatharticsPhase 1, Phase 2520
50Neurotransmitter AgentsPhase 1, Phase 217734

Interventional clinical trials:

(show top 50)    (show all 54)
idNameStatusNCT IDPhase
1Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisUnknown statusNCT01669447Phase 4
2The Effect of Bevacizumab on Corneal NeovascularizationCompletedNCT00797303Phase 4
3Clinical Performance of Biofinity Toric Versus Air Optix for AstigmatismCompletedNCT01965288Phase 4
4Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell DeficiencyRecruitingNCT02577861Phase 4
5Strategies for Management of Corneal NeovascularisationNot yet recruitingNCT02594423Phase 4
6The Role of Amniotic Membrane Transplantation in Ocular Chemical BurnsUnknown statusNCT00370812Phase 2, Phase 3
7Low Dose Doxycycline in the Treatment of Corneal BurnUnknown statusNCT01886560Phase 2, Phase 3
8Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCompletedNCT00555594Phase 2, Phase 3
9Efficacy and Safety Study of Avastin to Treat Neovascularisation of the CorneaRecruitingNCT01501760Phase 3
10Mycotic Antimicrobial Localized Injection for Treatment of Corneal UlcersEnrolling by invitationNCT02731638Phase 3
11Bevacizumab for the Treatment of Corneal NeovascularizationUnknown statusNCT00992849Phase 2
12Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective DoseUnknown statusNCT02157987Phase 1, Phase 2
13Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell DeficiencyUnknown statusNCT00845117Phase 1, Phase 2
14Treatment of Corneal Neovascularization With Topical PazopanibCompletedNCT01257750Phase 1, Phase 2
15Topical IL-1-Ra for Treatment of Corneal NeovascularizationCompletedNCT00915590Phase 1, Phase 2
16Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalCompletedNCT01072357Phase 1, Phase 2
17Amniotic Membrane Graft In Syntomathic Bullous KeratopathyCompletedNCT01926535Phase 2
18Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex VivoCompletedNCT01470573Phase 2
19Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) PatientsCompletedNCT00736307Phase 1, Phase 2
20Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot StudyRecruitingNCT01843101Phase 2
21A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalRecruitingNCT01996826Phase 1, Phase 2
22Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter TrialRecruitingNCT02318485Phase 2
23Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell DeficiencyRecruitingNCT01756365Phase 1, Phase 2
24Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)RecruitingNCT02975557Phase 1, Phase 2
25Cultivated Autologous Oral Mucosal Epithelial Transplantation for the Treatment of Ocular Surface DiseasesActive, not recruitingNCT02739113Phase 1, Phase 2
26Transplantation of Autologous Oral Mucosal Epithelial Stem Cell Sheet for Treating Limbal Stem Cell Deficiency DiseaseEnrolling by invitationNCT03015779Phase 1, Phase 2
27Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal NeovascularizationNot yet recruitingNCT02797704Phase 1, Phase 2
28Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar KeratoplastyNot yet recruitingNCT02424006Phase 1, Phase 2
29Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell DeficiencySuspendedNCT00348114Phase 2
30Topical Avastin for Treatment of Corneal NeovascularizationCompletedNCT00559936Phase 1
31Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)CompletedNCT00681889Phase 1
32Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant SurgeryCompletedNCT00769145Phase 1
33Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01075347Phase 1
34Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01031888Phase 1
35Ranibizumab for the Inhibition of Neovascularization in PterygiaCompletedNCT00768963Phase 1
36The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)CompletedNCT02649621Phase 1
37Bevacizumab Injection for Recurrent PterygiumCompletedNCT02007174Phase 1
38Using Aflibercept Injection to Treat Blood Vessel Growth Over the CorneaTerminatedNCT01868360Phase 1
39Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory ConditionsWithdrawnNCT02042027Phase 1
40Evaluation of Biosynthetic Constructs to Replace Donor CorneasWithdrawnNCT02374723Phase 1
41Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture MediaUnknown statusNCT00623584
42Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal NeovascularizationCompletedNCT00512876
43Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal NeovascularizationCompletedNCT00004430
44Photodynamic Therapy With Verteporfin for Corneal NeovascularizationCompletedNCT00471406
45Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal NeovasculizationCompletedNCT00681603
46Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to TrabeculectomyCompletedNCT01425112
47Vistakon Investigational Lens Worn as a Single Use Daily WearCompletedNCT01031004
48Assessment of Daily Disposable Silicone Hydrogel Lens WearCompletedNCT01093625
49Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical StudyCompletedNCT02637804
50Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic PatientsCompletedNCT00382603

Search NIH Clinical Center for Corneal Neovascularization


Cochrane evidence based reviews: corneal neovascularization

Genetic Tests for Corneal Neovascularization

About this section

Genetic tests related to Corneal Neovascularization:

id Genetic test Affiliating Genes
1 Corneal Neovascularization26

Anatomical Context for Corneal Neovascularization

About this section

MalaCards organs/tissues related to Corneal Neovascularization:

35
Eye, Endothelial, Neutrophil, Brain

Animal Models for Corneal Neovascularization or affiliated genes

About this section

MGI Mouse Phenotypes related to Corneal Neovascularization:

40 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053899.0CXCL12, FGF2, FLT1, PLG, SERPINF1, THBS1
2MP:00053908.3CD36, FGF2, KDR, SERPINF1, THBS1, VEGFA
3MP:00053818.2CD36, PLG, SERPINF1, SLIT2, THBS1, VEGFA
4MP:00053798.2CD36, PLG, SERPINF1, SLIT2, THBS1, VEGFA
5MP:00053708.2CD36, CXCL12, KDR, PLG, THBS1, VEGFA
6MP:00053767.7CD36, FGF2, FLT1, KDR, PLG, TEK
7MP:00053877.6CD36, CXCL12, FLT1, KDR, PLG, SERPINF1
8MP:00053697.5CD36, CXCL12, FGF2, FLT1, KDR, TEK
9MP:00053847.1CD36, CXCL12, FGF2, FLT1, KDR, PLG
10MP:00053857.0CD36, CXCL12, FGF2, FLT1, KDR, PLG
11MP:00053977.0CD36, CXCL12, FGF2, FLT1, KDR, PLG
12MP:00036316.8CD36, CXCL12, FGF2, FLT1, KDR, PLG
13MP:00107686.7CD36, CXCL12, FGF2, FLT1, KDR, PLG
14MP:00053916.6CD36, FGF2, FLT1, KDR, PLG, SERPINF1

Publications for Corneal Neovascularization

About this section

Articles related to Corneal Neovascularization:

(show top 50)    (show all 412)
idTitleAuthorsYear
1
Quantitative proteomic analysis of mice corneal tissues reveals angiogenesis-related proteins involved in corneal neovascularization. (27049463)
2016
2
Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats. (27920521)
2016
3
Interleukin (IL)-17A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model. (27419340)
2016
4
A Novel Peptide Derived from Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization. (27618679)
2016
5
Corneal Angiography for Guiding and Evaluating Fine-Needle Diathermy Treatment of Corneal Neovascularization. (25841974)
2015
6
Therapeutic effects of topical netrin-4 inhibits corneal neovascularization in alkali-burn rats. (25853509)
2015
7
Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization. (25640924)
2015
8
Keratocytes Create Stromal Spaces to Promote Corneal Neovascularization Via MMP13 Expression. (25190659)
2014
9
Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization. (25309995)
2014
10
Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization. (25090164)
2014
11
Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy. (25540752)
2014
12
Inhibitory Effect of Sub-conjunctival Tocilizumab on Alkali Burn Induced Corneal Neovascularization in Rats. (24910898)
2014
13
Angiopoietin-1 is regulated by miR-204 and contributes to corneal neovascularization in KLEIP-deficient mice. (24917145)
2014
14
Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model. (24145627)
2013
15
The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits. (23739149)
2013
16
Corneal neovascularization: An enigma. (24379562)
2013
17
The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization. (23404727)
2013
18
The association between corneal neovascularization and visual acuity: a systematic review. (22103683)
2013
19
Anti-VEGF Therapy (Bevacizumab) for Sulfur Mustard-Induced Corneal Neovascularization Associated with Delayed Limbal Stem Cell Deficiency in Rabbits. (24215293)
2013
20
Managements for corneal neovascularization. (24055908)
2013
21
Minocycline inhibits alkali burn-induced corneal neovascularization in mice. (22848638)
2012
22
Preliminary studies of the effects of vascular adhesion protein-1 inhibitors on experimental corneal neovascularization. (21331460)
2011
23
(-)-Epigallocatechin 3-gallate (EGCG) at the ocular surface inhibits corneal neovascularization. (20971568)
2011
24
Prevention of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with its topical form in experimental rats. (21212709)
2011
25
The effect of doxycycline temperature-sensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in rats. (20953876)
2011
26
Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice. (20640436)
2011
27
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization. (20857116)
2011
28
Potential anti-angiogenic role of Slit2 in corneal neovascularization. (20298689)
2010
29
Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. (21077280)
2010
30
The effect of bevacizumab on corneal neovascularization in rabbits. (20714387)
2010
31
A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization. (20450250)
2010
32
Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist. (19458323)
2009
33
Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization. (18812781)
2008
34
Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. (18580272)
2008
35
Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages. (18776949)
2008
36
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. (17198016)
2007
37
Alkali-induced corneal neovascularization is independent of CXCR2-mediated neutrophil infiltration. (17251813)
2007
38
Effects of corneal neovascularization on the manifestations of Avellino corneal dystrophy (granular corneal dystrophy type II). (17102666)
2006
39
Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. (16458678)
2006
40
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. (15851564)
2005
41
Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand. (15721625)
2005
42
Experimental inhibition of corneal neovascularization by endostatin gene transfection in vivo. (14687476)
2003
43
Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. (12506066)
2003
44
Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane]. (14769230)
2003
45
Lipid hydroperoxide induced corneal neovascularization in hyperglycemic rabbits. (12518243)
2002
46
Macrophage inflammatory protein-2 and vascular endothelial growth factor regulate corneal neovascularization induced by infection with Pseudomonas aeruginosa in mice. (12121220)
2002
47
Topically applied water extract of propolis to suppress corneal neovascularization in rabbits. (10474071)
1999
48
Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization. (2459642)
1988
49
Experimental corneal neovascularization: biomicroscopic, angiographic, and morphologic correlation. (2419029)
1985-1986
50
The effects of leukocyte depletion on corneal neovascularization. (621924)
1978

Variations for Corneal Neovascularization

About this section

Expression for genes affiliated with Corneal Neovascularization

About this section
Search GEO for disease gene expression data for Corneal Neovascularization.

Pathways for genes affiliated with Corneal Neovascularization

About this section

Pathways related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 30)
idSuper pathwaysScoreTop Affiliating Genes
19.6FGF2, KDR, VEGFA
29.6FGF2, KDR, VEGFA
3
Show member pathways
9.6FLT1, KDR, VEGFA
4
Show member pathways
9.6FLT1, KDR, VEGFA
59.6FLT1, KDR, VEGFA
6
Show member pathways
9.6FLT1, KDR, VEGFA
79.6FLT1, KDR, VEGFA
89.5FLT1, TEK, VEGFA
99.5HRG, PLG
10
Show member pathways
9.5FLT1, KDR, TEK
119.3FGF2, FLT1, KDR, VEGFA
129.3FGF2, FLT1, KDR, VEGFA
139.3FGF2, KDR, PLG, VEGFA
149.2FGF2, KDR, THBS1, VEGFA
15
Show member pathways
9.2CD36, KDR, THBS1
169.2FGF2, FLT1, KDR, TEK
179.1FGF2, FLT1, SLIT2, VEGFA
18
Show member pathways
9.1FGF2, KDR, PLG, THBS1
19
Show member pathways
9.1CXCL12, FGF2, FLT1, KDR
20
Show member pathways
9.1CXCL12, FGF2, FLT1, KDR
219.1CXCL12, FLT1, TEK, VEGFA
229.0CXCL12, FGF2, PLG, THBS1
23
Show member pathways
8.9FGF2, FLT1, KDR, TEK, VEGFA
24
Show member pathways
8.8FGF2, FLT1, KDR, TEK, THBS1
25
Show member pathways
8.5FGF2, FLT1, KDR, TEK, THBS1, VEGFA
268.5FGF2, FLT1, KDR, TEK, THBS1, VEGFA
27
Show member pathways
8.5CXCL12, FGF2, FLT1, KDR, TEK, VEGFA
28
Show member pathways
8.5CXCL12, FGF2, FLT1, KDR, TEK, VEGFA
29
Show member pathways
8.2CD36, FGF2, KDR, SLIT2, TEK, VEGFA
30
Show member pathways
8.2CD36, CXCL12, KDR, PLG, THBS1, VEGFA

GO Terms for genes affiliated with Corneal Neovascularization

About this section

Cellular components related to Corneal Neovascularization according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.5HRG, PLG, THBS1, VEGFA
2cell surfaceGO:00099868.3CD36, PLG, TEK, THBS1, VEGFA
3extracellular spaceGO:00056157.1CD36, CXCL12, FGF2, FLT1, PLG, SERPINF1
4extracellular regionGO:00055766.5CXCL12, FGF2, HRG, KDR, PLG, SERPINF1

Biological processes related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 48)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of phospholipase C activityGO:001086310.6FGF2, FLT1
2positive regulation of vascular endothelial growth factor receptor signaling pathwayGO:003094910.6FLT1, VEGFA
3positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.6KDR, VEGFA
4embryonic morphogenesisGO:004859810.5FGF2, FLT1
5positive regulation of positive chemotaxisGO:005092710.5KDR, VEGFA
6regulation of cGMP metabolic processGO:003082310.5THBS1, VEGFA
7negative regulation of endothelial cell apoptotic processGO:200035210.4KDR, TEK
8sprouting angiogenesisGO:000204010.3TEK, THBS1
9branching morphogenesis of an epithelial tubeGO:004875410.3SLIT2, VEGFA
10positive regulation of axon extension involved in axon guidanceGO:004884210.3CXCL12, VEGFA
11induction of positive chemotaxisGO:005093010.3CXCL12, VEGFA
12positive regulation of blood vessel endothelial cell migrationGO:004353610.2FGF2, THBS1, VEGFA
13positive regulation of phosphatidylinositol 3-kinase activityGO:004355210.2FGF2, FLT1, TEK
14negative regulation of endothelial cell chemotaxisGO:200102710.2HRG, THBS1
15fibrinolysisGO:004273010.1HRG, PLG
16negative regulation of lamellipodium assemblyGO:001059310.1HRG, SLIT2
17positive regulation of MAP kinase activityGO:004340610.0FGF2, FLT1, VEGFA
18positive chemotaxisGO:005091810.0CXCL12, FGF2, VEGFA
19positive regulation of protein kinase B signalingGO:005189710.0FGF2, TEK, THBS1
20positive regulation of phosphatidylinositol 3-kinase signalingGO:00140689.9FLT1, KDR, TEK
21cellular response to vascular endothelial growth factor stimulusGO:00359249.9FLT1, KDR, VEGFA
22vascular endothelial growth factor receptor signaling pathwayGO:00480109.9FLT1, KDR, VEGFA
23protein autophosphorylationGO:00467779.9FLT1, KDR, TEK
24negative regulation of inflammatory responseGO:00507289.9SERPINF1, SLIT2, TEK
25positive regulation of blood coagulationGO:00301949.9CD36, THBS1
26cell migration involved in sprouting angiogenesisGO:00020429.8FGF2, KDR, SLIT2, VEGFA
27positive regulation of protein phosphorylationGO:00019349.8FGF2, KDR, TEK, VEGFA
28negative regulation of fibrinolysisGO:00519189.7HRG, PLG, THBS1
29endothelial cell proliferationGO:00019359.7TEK, XBP1
30transmembrane receptor protein tyrosine kinase signaling pathwayGO:00071699.7FLT1, KDR, TEK
31peptidyl-tyrosine phosphorylationGO:00181089.7FGF2, FLT1, KDR, TEK
32positive regulation of MAPK cascadeGO:00434109.6CD36, FLT1, KDR
33negative regulation of endothelial cell migrationGO:00105969.6SERPINF1, SLIT2, THBS1
34negative regulation of blood vessel endothelial cell migrationGO:00435379.5FGF2, HRG, THBS1
35positive regulation of endothelial cell migrationGO:00105959.5FGF2, KDR, TEK, THBS1, VEGFA
36positive regulation of focal adhesion assemblyGO:00518949.5HRG, KDR, TEK, VEGFA
37chemotaxisGO:00069359.4CXCL12, FGF2, HRG
38positive regulation of endothelial cell proliferationGO:00019389.3CXCL12, FGF2, KDR, TEK, VEGFA
39negative regulation of angiogenesisGO:00165259.3HRG, SERPINF1, TEK, THBS1
40platelet degranulationGO:00025768.9CD36, HRG, PLG, THBS1, VEGFA
41positive regulation of angiogenesisGO:00457668.9FGF2, FLT1, KDR, TEK, THBS1, VEGFA
42positive regulation of cell proliferationGO:00082848.9CXCL12, FGF2, FLT1, KDR, VEGFA
43positive regulation of cell migrationGO:00303358.7CXCL12, FLT1, KDR, THBS1, VEGFA
44positive regulation of ERK1 and ERK2 cascadeGO:00703748.7CD36, FGF2, KDR, TEK
45response to hypoxiaGO:00016668.6CXCL12, FLT1, TEK, THBS1, VEGFA
46immune responseGO:00069558.5CD36, CXCL12, THBS1, XBP1
47negative regulation of apoptotic processGO:00430668.5KDR, TEK, THBS1, VEGFA, XBP1
48angiogenesisGO:00015257.9FGF2, FLT1, HRG, KDR, TEK, VEGFA

Molecular functions related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1vascular endothelial growth factor-activated receptor activityGO:000502110.4FLT1, KDR
2transforming growth factor beta bindingGO:005043110.0CD36, THBS1
3fibronectin bindingGO:00019689.9THBS1, VEGFA
4low-density lipoprotein particle bindingGO:00301699.9CD36, THBS1
5heparan sulfate proteoglycan bindingGO:00433959.8HRG, SLIT2
6chemoattractant activityGO:00420569.8CXCL12, FGF2, VEGFA
7growth factor bindingGO:00198389.8FLT1, KDR, TEK
8proteoglycan bindingGO:00433949.7SLIT2, THBS1
9growth factor activityGO:00080839.5CXCL12, FGF2, VEGFA
10transmembrane receptor protein tyrosine kinase activityGO:00047149.4FLT1, KDR, TEK
11protein tyrosine kinase activityGO:00047139.2FGF2, KDR, TEK
12heparin bindingGO:00082018.6FGF2, HRG, SLIT2, THBS1, VEGFA

Sources for Corneal Neovascularization

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet